External Quality Assessment of Bone Metabolism Marker Assays. Initial Experiences in a UK NEQAS Programme

This paper reports on a pilot external quality assessment scheme for bone markers including serum bone alkaline phosphatase and procollagen 1-carboxy terminal propeptide together with urine deoxypyridinoline, N- and C-telopeptides. The data shows poor numerical agreement between commercial assays, b...

Full description

Saved in:
Bibliographic Details
Published inClinical chemistry and laboratory medicine Vol. 38; no. 11; pp. 1121 - 1124
Main Authors Whitham, Karen Marie, Milford-Ward, Anthony
Format Journal Article Conference Proceeding
LanguageEnglish
Published Berlin Walter de Gruyter 12.11.2000
New York, NY
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This paper reports on a pilot external quality assessment scheme for bone markers including serum bone alkaline phosphatase and procollagen 1-carboxy terminal propeptide together with urine deoxypyridinoline, N- and C-telopeptides. The data shows poor numerical agreement between commercial assays, between-laboratory imprecision that could be improved, and the need for international standardisation of assays.
Bibliography:istex:059BC11AF0B72326CA7BDB4B4867A3B2A2744C9B
ArticleID:cclm.38.11.1121
ark:/67375/QT4-6LRWSD9T-W
cclm.2000.168.pdf
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1434-6621
1437-4331
DOI:10.1515/CCLM.2000.168